Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.01M Buy
14,232
+527
+4% +$188K 0.08% 97
2025
Q4
$4.49M Buy
13,705
+190
+1% +$60.3K 0.07% 109
2025
Q3
$3.81M Sell
13,515
-314
-2% -$91.1K 0.06% 124
2025
Q2
$3.86M Sell
13,829
-556
-4% -$158K 0.07% 110
2025
Q1
$4.48M Buy
14,385
+795
+6% +$235K 0.08% 86
2024
Q4
$3.54M Sell
13,590
-896
-6% -$266K 0.07% 105
2024
Q3
$4.67M Buy
14,486
+240
+2% +$78.5K 0.09% 76
2024
Q2
$4.45M Buy
14,246
+563
+4% +$165K 0.09% 74
2024
Q1
$3.89M Sell
13,683
-184
-1% -$53.8K 0.08% 82
2023
Q4
$3.99M Buy
13,867
+81
+0.6% +$22.1K 0.09% 76
2023
Q3
$3.71M Buy
13,786
+2,375
+21% +$593K 0.1% 76
2023
Q2
$2.53M Sell
11,411
-1,958
-15% -$454K 0.06% 104
2023
Q1
$3.23M Buy
13,369
+1,234
+10% +$303K 0.09% 84
2022
Q4
$3.19M Buy
12,135
+468
+4% +$125K 0.09% 73
2022
Q3
$2.63M Sell
11,667
-385
-3% -$93.3K 0.09% 72
2022
Q2
$2.93M Buy
12,052
+429
+4% +$105K 0.1% 71
2022
Q1
$2.81M Buy
11,623
+664
+6% +$153K 0.08% 78
2021
Q4
$2.46M Buy
10,959
+15
+0.1% +$3.17K 0.08% 92
2021
Q3
$2.33M Sell
10,944
-1,779
-14% -$409K 0.08% 92
2021
Q2
$3.1M Buy
12,723
+988
+8% +$243K 0.12% 65
2021
Q1
$2.92M Buy
11,735
+967
+9% +$231K 0.13% 65
2020
Q4
$2.48M Buy
10,768
+2,096
+24% +$483K 0.12% 67
2020
Q3
$2.2M Buy
8,672
+1,155
+15% +$286K 0.12% 70
2020
Q2
$1.77M Buy
7,517
+218
+3% +$49.7K 0.11% 72
2020
Q1
$1.48M Sell
7,299
-130
-2% -$28.4K 0.13% 64
2019
Q4
$1.79M Buy
7,429
+702
+10% +$155K 0.13% 66
2019
Q3
$1.3M Buy
6,727
+775
+13% +$149K 0.11% 74
2019
Q2
$1.1M Sell
5,952
-599
-9% -$107K 0.09% 84
2019
Q1
$1.25M Sell
6,551
-970
-13% -$185K 0.11% 74
2018
Q4
$1.46M Buy
7,521
+1,135
+18% +$221K 0.14% 62
2018
Q3
$1.32M Buy
6,386
+256
+4% +$50.5K 0.13% 69
2018
Q2
$1.13M Buy
6,130
+986
+19% +$174K 0.13% 76
2018
Q1
$877K Buy
5,144
+1,317
+34% +$242K 0.1% 74
2017
Q4
$666K Buy
3,827
+252
+7% +$44.6K 0.08% 109
2017
Q3
$667K Buy
3,575
+642
+22% +$114K 0.09% 91
2017
Q2
$505K Buy
2,933
+58
+2% +$9.43K 0.07% 113
2017
Q1
$472K Buy
2,875
+147
+5% +$24.4K 0.07% 124
2016
Q4
$399K Sell
2,728
-237
-8% -$35.7K 0.07% 117
2016
Q3
$495K Buy
2,965
+654
+28% +$111K 0.07% 96
2016
Q2
$352K Buy
2,311
+169
+8% +$26.3K 0.05% 111
2016
Q1
$321K Buy
2,142
+258
+14% +$38.3K 0.05% 115
2015
Q4
$306K Sell
1,884
-1,393
-43% -$219K 0.06% 107
2015
Q3
$453K Buy
3,277
+790
+32% +$125K 0.1% 61
2015
Q2
$382K Buy
2,487
+74
+3% +$11.9K 0.08% 87
2015
Q1
$386K Buy
2,413
+124
+5% +$19.5K 0.09% 84
2014
Q4
$365K Buy
2,289
+57
+3% +$8.88K 0.09% 85
2014
Q3
$314K Hold
2,232
0.1% 89
2014
Q2
$264K Sell
2,232
-23
-1% -$2.66K 0.09% 96
2014
Q1
$278K Sell
2,255
-324
-13% -$39.3K 0.11% 59
2013
Q4
$294K Hold
2,579
0.11% 62
2013
Q3
$289K Sell
2,579
-46
-2% -$4.99K 0.12% 60
2013
Q2
$259K Buy
+2,625
New +$272K 0.13% 66

Other funds holding AMGN

SignatureFD's AMGN Position: Q1 2026 in Review

SignatureFD increased its Amgen (AMGN) stake by 3.8% in Q1 2026, buying an estimated $188K and bringing the position to 14,232 shares worth $5.01M. The position accounts for 0.08% of the portfolio, ranked #97.

SignatureFD first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • SignatureFD held 14,232 shares of Amgen worth $5.01M as of Q1 2026.
  • SignatureFD bought 527 Amgen shares in Q1 2026, an estimated $188K.
  • Amgen made up 0.08% of SignatureFD's portfolio in Q1 2026, its #97 holding.
  • SignatureFD first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
  • 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on SignatureFD's 13F filing for Q1 2026, filed 7 Apr 2026.